Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients

摘要

Two weeks on, one off schedule of sunitinib should not be used in all patients who experienced dose-limiting toxicity but only for patients who had "schedule-limiting toxicities".